Home  |  About us  |  Editorial board  |  Current issue  |  Archives  |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 409Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Phase 0 clinical trials in oncology new drug development

Gupta Umesh Chandra, Bhatia Sandeep, Garg Amit, Sharma Amit, Choudhary Vaibhav

Year : 2011| Volume: 2| Issue : 1 | Page no: 13-22

   This article has been cited by
1 Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?
Zhe Li,Qin Li,Jun Wu,Manyuan Wang,Junxian Yu
Molecules. 2016; 21(10): 1331
[Pubmed]  [Google Scholar] [DOI]
2 [18F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatment
Dmitry Soloviev,David Lewis,Davina Honess,Eric Aboagye
European Journal of Cancer. 2012; 48(4): 416
[Pubmed]  [Google Scholar] [DOI]


Read this article